Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:10/11/2018)... (PRWEB) , ... October 11, 2018 , ... ... of Ambulatory medical clinic of all sizes and specialties. PrognoCIS , their ... based care for their patients. , Greater Houston Healthconnect (GHH), the region’s health ...
(Date:10/6/2018)... ... October 06, 2018 , ... ... treatment professionals who treat the full spectrum of eating disorders (ED), today welcomed ... Council. , “As with each of our Presidents Council members, it is an ...
(Date:10/5/2018)... ... October 05, 2018 , ... Ophthalmic ... support of the 14th annual Major Rob Soltes Memorial Golf Tournament benefitting the ... will be held on Columbus Day, Monday, October 8th at Oak Creek Golf ...
(Date:10/5/2018)... ... October 05, 2018 , ... Access ... annual conference on the latest innovations in health care and IT. Cerner, a ... throughout downtown Kansas City, Missouri. , "We’re really all about three things: closing ...
(Date:10/5/2018)... (PRWEB) , ... October 05, 2018 , ... Woman-owned company, ... of October in support of finding the cure for breast cancer. The custom made ... began in 2015, when a FlagandBanner.com customer, Geoffrey Jackson, purchased a pink New Mexico ...
Breaking Medicine News(10 mins):
... the rate of common, costly and potentially lethal catheter-related ... using cheap//, low-tech, common-sense measures like hand washing, timely ... than the groin to place lines when possible, according ... any more not to do these relatively simple things,” ...
... to investigate the reason why the common parasite Toxoplasma,// ... make many others seriously ill. , ,Toxoplasma is ... cats, but can also be passed on by many ... called toxoplasmosis, which in normal circumstances is not harmful, ...
... a zebrafish loses a chunk of its tail fin, it’ll ... a zebrafish can replace surprisingly complex body parts. A tail ... is a very intricate structure. It is the fish version ... cold-blooded animals re-grow missing tails and other appendages has fascinated ...
... guru Baba Ramdev said here Wednesday that soft drinks //should ... only fruit juice and milk to keep diseases away. ... Science College ground here at a camp, Ramdev said: "Take ... everyday early morning rather than consuming cold drinks., ,"Cold ...
... a modified strain, has led to the death of a ... pre mature babies are undergoing treatment. ,The babies ... after they were found to be carriers of Panton-Valentine Leukocidin ... ,Hospital authorities have confirmed that the baby died due ...
... in New York are having a nice holiday with medical ... is called Clown Care and believes in the saying “laughter ... New York-Presbyterian Hospital runs this program. It is a residential ... introduced by Michael Christensen, co-founder of Big Apple Circus. ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products:
(Date:10/11/2018)... (PRWEB) , ... October 11, 2018 , ... ... and e-discovery software for corporate law departments and law firms, today announced it ... Attendees should visit booth 110 to learn how corporate legal departments are using ...
(Date:10/7/2018)... ... October 07, 2018 , ... Dr. B. Aviva Preminger, elite plastic surgeon of ... an Ivy League-educated, Board Certified woman plastic surgeon specializing in cosmetic and reconstructive surgery ... for their exclusivity, and luxurious lifestyle publication is privileged to present Dr. Preminger as ...
(Date:10/6/2018)... , ... October 06, 2018 , ... ... than 20 years. Number One On The List services improve search engine ranking ... Site Conversion, Modernize Website, Press Releases, Marketing Programs, Email Newsletters, SEO, Packages of ...
Breaking Medicine Technology:
... Investigative Dermatology, FREEPORT, N.Y., May 16, 2007 ... clinical data that indicates,that OCTN-1 skin cells ... L-ergothioneine (EGT) as a protector against oxidative,damage, ... more powerful and,efficient antioxidant than idebenone, scavenging ...
... demonstrate safety and,efficacy of first FDA-approved nebulized formoterol ... NAPA, Calif., May 16, 2007 /PRNewswire/ -- Dey, ... given at the,International Conference of the American Thoracic ... Center in San Francisco. The,presentations will detail Phase ...
Cached Medicine Technology: